Dr Reddy's Labs forays into trade generics business in India with launch of new division
Advertisement
Hyderabad: Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced its entry into the trade generics business in India with the launch of its new dedicated division ‘RGenX’.
"Through this, Dr. Reddy’s aims to provide patients with access to a wider range of products and increased affordability," the company
The new business will further the company’s goal of reaching over 1.5 billion patients by 2030. Dr. Reddy’s aims to roll out its trade generics across cities and towns in India, including rural areas. The company will work closely with its channel partners to ensure availability of its products.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.